Nasenspray-Ratiopharm® Erwachsene (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. By stimulating alpha‑1 and alpha‑2 receptors on the blood vessels of the nasal mucosa, it causes vasoconstriction, which reduces blood flow, decreases mucosal edema, and opens the nasal airway, providing rapid decongestion.

The appropriate dose and frequency are determined by the prescribing healthcare professional. Typically, one spray per nostril is administered every 8‑10 hours, not exceeding three days of continuous use, but the exact regimen should follow the prescriber’s instructions.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using the product to weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details, and any necessary import documentation.

Xylometazoline is an imidazoline‑type decongestant, offering rapid onset of action similar to phenylephrine‑based sprays. Compared with oxymetazoline, it has a comparable efficacy profile but may have a slightly shorter duration of action. Choice of product often depends on individual tolerance, physician preference, and specific formulation characteristics.

Store the nasal spray at room temperature, ideally below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and store it out of reach of children. Do not freeze the product; if the spray becomes excessively warm, allow it to return to ambient temperature before use.

The product is a nasal spray intended for intranasal use only. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and press the pump to deliver one spray. Repeat in the other nostril if required, following the prescriber’s dosing instructions.

Serious risks include rebound congestion (rhinitis medicamentosa) if used longer than three days, severe hypertension or hypertensive crisis, cardiac arrhythmias, and rare allergic reactions such as angioedema or anaphylaxis. Users should discontinue the spray and seek medical attention if any severe symptoms develop.

The spray should not be used by children under 12 years of age, individuals with known hypersensitivity to Xylometazoline or any excipients, patients with severe hypertension or uncontrolled cardiovascular disease, and those taking monoamine oxidase inhibitors without medical supervision.